You are here: Home > Cannabinoids (former) > Treating depression with cannabinoids

Cannabinoids 2008;3(2):8-10 (22 June 2008)

Original article

Treating depression with cannabinoids

Kurt Blaas

Lindengasse 27/10, 1070 Vienna, Austria, drblaas@blowdoc.at

Although a variety of drugs are available for the treatment of depression, therapy is not effective in all cases and finding alternative options is desirable. Results from animal studies, anecdotal ex-perience reported by patients using cannabis and observations from clinical studies where can-nabinoids were used in serious diseases suggest an anti-depressive potential of cannabinoid recep-tor agonists. From 2003 to 2006, 75 patients suffering from depression, stress and burnout syn-drome were successfully treated in a practice for general medicine with the cannabis ingredient dronabinol, alone or in combination with other antidepressants. Two case studies will be pre-sented. The presented observations suggest that dronabinol has an antidepressive potential that can readily be used in medical practice.

Keywords
Depression, burnout, cannabinoid, cannabis, dronabinol

PDF of the full text ]

Online Events 2020

Please find all information of IACM Online Events including free videos of the webinars here.

Conference 2022

The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.